Merck: Number of Employees 2010-2023 | MRK

Interactive chart of Merck (MRK) annual worldwide employee count from 2010 to 2023.
  • Merck total number of employees in 2023 was 72,000, a 4.35% increase from 2022.
  • Merck total number of employees in 2022 was 69,000, a 1.47% increase from 2021.
  • Merck total number of employees in 2021 was 68,000, a 8.11% decline from 2020.
  • Merck total number of employees in 2020 was 74,000, a 4.23% increase from 2019.
Merck Annual Employee Count
2023 72,000
2022 69,000
2021 68,000
2020 74,000
2019 71,000
2018 69,000
2017 69,000
2016 68,000
2015 68,000
2014 70,000
2013 76,000
2012 83,000
2011 86,000
2010 94,000
2009 100,000
Sector Industry Market Cap Revenue
Medical Large Cap Pharmaceutical $321.391B $60.115B
Merck & Co. boasts more than six blockbuster drugs in its portfolio with PD-L1 inhibitor, Keytruda, approved for several types of cancer. Keytruda has played an instrumental role in driving Merck's steady revenue growth in the past few years. Well-known products in Merck's portfolio include Keytruda, Simponi , Januvia and Janumet, Bridion, Isentress, ProQuad, Gardasil, Pneumovax 23, RotaTeq and Belsomra. Merck made its biggest acquisition of Schering-Plough and sold off its Consumer Care business to Bayer. Other key acquisitions include Idenix Pharmaceuticals, Cubist Pharmaceuticals, Rigontec, ArQule and Acceleron Pharma. IMerck spun off products from its Women's Health unit, legacy drugs and biosimilar products into a new publicly traded company called Organon & Co.
Stock Name Country Market Cap PE Ratio
Eli Lilly (LLY) United States $708.528B 117.99
Novo Nordisk (NVO) Denmark $577.276B 47.56
Johnson & Johnson (JNJ) United States $360.407B 14.30
AbbVie (ABBV) United States $300.196B 15.26
AstraZeneca (AZN) United Kingdom $219.666B 19.46
Novartis AG (NVS) Switzerland $198.840B 14.10
Pfizer (PFE) United States $149.038B 14.38
Sanofi (SNY) $120.637B 10.86
Innoviva (INVA) United States $0.959B 6.77